Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01977846 · ClinicalTrials.gov registry record
A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies
A clinical trial, sponsored by Foundation Fighting Blindness.
- Completed
- Registry status
- 259
- Enrollment target
NCT01977846 is a clinical trial that has completed, run by Foundation Fighting Blindness. The registered enrollment target is 259 participants.
The verdict
NCT01977846 has completed, sponsored by Foundation Fighting Blindness.
- COMPLETED
- Registry status
- 259 participants
- Enrollment target
Study Summary
Stargardt disease is currently an incurable and untreatable macular dystrophy that causes severe visual loss in children and young adults, thereby causing enormous morbidity with economic, psychological, emotional, and social implications. There are no FDA approved therapeutic treatments for this disease. Therefore, the objective of this study is to collect natural history data from a large population of children and adults in order to evaluate possible efficacy measures for planned clinical trials. Participants will be recruited from each Investigator's own patient population as the study requires the availability of both multiyear retrospective data, as well as ongoing prospectively collected data. A concurrent ancillary study (SMART study) is also being conducted with a subset of the prospective study patients during their regular ProgSTAR study visits to expand the collection of retinal images to include microperimetry measurements gathered under scotopic (low light) conditions.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2013-08 |
| Est. Completion | 2017-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01977846
The ClinicalTrials.gov registry entry for NCT01977846 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Foundation Fighting Blindness, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01977846 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01977846 about?
NCT01977846 is a clinical study titled "A Natural History of the Progression of Stargardt Disease: Retrospective and Prospective Studies". Stargardt disease is currently an incurable and untreatable macular dystrophy that causes severe visual loss in children and young adults, thereby causing enormous morbidity with economic, psychological, emotional, and social implications. There are no FDA approved therapeutic treatments for this di...
What is the current status of trial NCT01977846?
This trial is currently completed. The enrollment target is 259 participants. The study started on 2013-08. Estimated completion is 2017-02.
Who is sponsoring clinical trial NCT01977846?
This trial is sponsored by Foundation Fighting Blindness, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.